Fulcrum Therapeutics, Inc. · NASDAQ:FULC
Montanova Capital, LLC reported a 9.40% stake in Fulcrum Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 2, 2025
Montanova Capital, LLC reported a 9.40% stake in Fulcrum Therapeutics, Inc., 5,067,394 shares, as a passive investor on Mar 31, 2025. Filed May 2, 2025 (Schedule 13G/A).
- Stake
- 9.40%
- Shares
- 5,067,394
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 9.40% | 5,067,394 |
| AVERILL MASTER FUND, LTD. | 8.60% | 4,635,481 |
| AARON COWEN | 9.40% | 5,067,394 |
Source
Related
- Fulcrum Therapeutics, Inc.
- Montanova Capital, LLC
- Fulcrum Therapeutics, Inc. shareholders
- Schedule 13G/A · Montanova Capital, LLC · Aug 14, 2026
- Schedule 13G · Montanova Capital, LLC · Jan 6, 2025
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G · Nantahala Capital Management, LLC · Aug 14, 2026
- Schedule 13G · Bank of America Corp · Aug 3, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026